Advertisement

Sars Coronavirus Vaccine Development

  • Ralph S. Baric
  • Timothy Sheahan
  • Damon Deming
  • Eric Donaldson
  • Boyd Yount
  • Amy C. Sims
  • Rhonda S. Roberts
  • Matthew Frieman
  • Barry Rockx
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 581)

Keywords

Severe Acute Respiratory Syndrome Severe Acute Respiratory Syndrome Severe Acute Respiratory Syndrome Patient Epidemic Strain Venezuelan Equine Encephalitis Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    R. Baric, B. Yount, L. Lindesmith, et al. , Expression and self-assembly of norwalk virus capsid protein from Venezuelan equine encephalitis virus replicons, J. Virol. 76, 3023-3030 (2002).CrossRefPubMedGoogle Scholar
  2. 2.
    J. Cello, A. V. Paul, and E. Wimmer, Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template, Science 297, 1016-1018 (2002).CrossRefPubMedGoogle Scholar
  3. 3.
    Chinese SARS Molecular Epidemiology Consortium, Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China, Science 303, 1666-1669 (2004).Google Scholar
  4. 4.
    Y. Guan, B. J. Zheng, Y. Q. He, et al. , Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China, Science 302, 276-278 (2003).CrossRefPubMedGoogle Scholar
  5. 5.
    Y. Han, H. Geng, W. Feng, et al. , A follow-up of 69 discharged SARS patients, J. Tradit. Chin. Med. 23, 214-217 (2003).PubMedGoogle Scholar
  6. 6.
    S. Jiang, Y. He, and S. Liu, SARS vaccine development, Emerg. Infect. Dis. 11, 1016-1020 (2005).PubMedGoogle Scholar
  7. 7.
    B. Kan, M. Wang, H. Jing, et al. , Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms, J. Virol. 79, 11892-11900 (2005).CrossRefPubMedGoogle Scholar
  8. 8.
    D. Kobasa, A. Takada, K. Shinva, et al. , Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus, Nature 431, 703-707 (2004).CrossRefPubMedGoogle Scholar
  9. 9.
    K. Kuba, Y. Imai, S. Rao, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury, Nat. Med. 11, 875-879 (2005).CrossRefPubMedGoogle Scholar
  10. 10.
    S. C. Lai, P. C. Chong, C. T. Yeh, et al. , Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of SARS-CoV, J. Biomed. Sci. 12, 1-17 (2005).CrossRefGoogle Scholar
  11. 11.
    W. Li, M. Moore, N. Vasilieva, et al. , Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature 426, 450-454 (2003).CrossRefPubMedGoogle Scholar
  12. 12.
    M. A. Marra, S. J. M. Jones, C. R. Astell, et al. , The genome sequence of the SARS-associated coronavirus, Science 300, 1399-1404 (2003).CrossRefPubMedGoogle Scholar
  13. 13.
    D. M. Murasko and J. Jiang, Response of aged mice to primary virus infections, Immunol. Rev. 205, 285-296 (2005).CrossRefPubMedGoogle Scholar
  14. 14.
    G. Pawelec, A. Akbar, C. Caruso, et al. , Human immunosenescence: is it infectious? Immunol. Rev. 205, 257-268 (2005).CrossRefPubMedGoogle Scholar
  15. 15.
    A. Roberts, C. Paddock, L. Vogel, E. Butler, S. Zaki, and K. Subbarao, Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans, J. Virol. 79, 5833-5838 (2005).CrossRefPubMedGoogle Scholar
  16. 16.
    P. A. Rota, M. S. Oberste, S. S. Monroe, et al. , Characterization of a novel coronavirus associated with severe acute respiratory syndrome, Science 300, 1394-1399 (2003).CrossRefPubMedGoogle Scholar
  17. 17.
    E. J. Snijder, P. J. Bredenbeek, J. C. Dobe, et al. , Unique and conserved features of genome and proteome of SARS-CoV, an early split-off from the coronavirus group 2 lineage, J. Mol. Biol. 331, 991-1004 (2003).CrossRefPubMedGoogle Scholar
  18. 18.
    J. Sui, W. Li, A. Murakami, et al. , Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association, Proc. Natl. Acad. Sci. USA 101, 2536-2541 (2004).CrossRefPubMedGoogle Scholar
  19. 19.
    R. A. Tripp, L. M. Haynes, D. Moore, et al. , Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins, J. Virol. Methods 128, 21-28 (2005).CrossRefPubMedGoogle Scholar
  20. 20.
    H. Weingarl, M. Czub, S. Chub, et al. , Immunization with modified vaccinia virus ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis virus in ferrets, J. Virol. 78, 12672-12676 (2004).CrossRefGoogle Scholar
  21. 21.
    Z. Yang, H. Werner, W. Kong, et al. , Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses, Proc. Natl. Acad. Sci. USA 102, 797-801 (2005).CrossRefPubMedGoogle Scholar
  22. 22.
    B. Yount, K. Curtis, E. Fritz, et al. , Reverse genetics with a full length infectious cDNA of the severe acute respiratory syndrome coronavirus, Proc. Natl. Acad. Sci. USA 100, 12995-13000 (2003).CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Ralph S. Baric
    • 1
  • Timothy Sheahan
    • 2
  • Damon Deming
    • 3
  • Eric Donaldson
    • 4
  • Boyd Yount
    • 5
  • Amy C. Sims
    • 6
  • Rhonda S. Roberts
    • 7
  • Matthew Frieman
    • 8
  • Barry Rockx
    • 9
  1. 1.University of North CarolinaChapel HillUSA
  2. 2.University of North CarolinaChapel HillUSA
  3. 3.University of North CarolinaChapel HillUSA
  4. 4.University of North CarolinaChapel HillUSA
  5. 5.University of North CarolinaChapel HillUSA
  6. 6.University of North CarolinaChapel HillUSA
  7. 7.University of North CarolinaChapel HillUSA
  8. 8.University of North CarolinaChapel HillUSA
  9. 9.University of North CarolinaChapel HillUSA

Personalised recommendations